Skip to content

Clinical trials

Phase 2 Hematologic Neoplasms trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 2 Status: Unknown status Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20092
20101
20111
20131
20141
20151
20172
20212
20222
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
First Affiliated Hospital of Zhejiang University3
Seoul National University Hospital2
Beijing 302 Hospital1
Cancer Research UK1
European Institute of Oncology1
Hospices Civils de Lyon1
Institut Paoli-Calmettes1
Melbourne Health1
MitoImmune Therapeutics1
Rabin Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms17
Graft vs Host Disease2
Bone Marrow Failure Disorders1
Bronchiolitis Obliterans Syndrome1
Lymphoma1
Multiple Myeloma1
Neoplasms1
Recurrence1
Stomatitis1
Vomiting1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.